Kazia Therapeutics (KZIA) Net Cash Flow (2012 - 2022)
Kazia Therapeutics' (KZIA) quarterly Net Cash Flow came in at $11.6 million in Q4 2022, up 239.44% YoY from $3.4 million in Q4 2021, and up 239.44% on a QoQ basis from -$8.3 million in Q4 2021.
Kazia Therapeutics (KZIA) Net Cash Flow (2012 - 2022) Analysis & Trends
Kazia Therapeutics (KZIA) has 7 years of Net Cash Flow data on file, last reported at $11.6 million in Q4 2022.
- Quarterly Net Cash Flow rose 239.44% year-over-year to $11.6 million in Q4 2022, while the trailing twelve-month figure through Jun 2024 was $11.6 million (up 253.55% YoY) and the FY2025 annual result came in at $1.7 million, up 173.07% from the prior year.
- Net Cash Flow advanced to $11.6 million in Q4 2022, from -$8.3 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $11.6 million in Q4 2022 to a low of -$9.0 million in Q4 2020.
- A 4-year average of -$1.9 million and a median of -$5.1 million in 2019 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2020 — Net Cash Flow sank 379.74% — and 2022, when it surged 239.44%.
- Tracing KZIA's Net Cash Flow over 4 years: stood at -$1.9 million in 2019, then slumped by 379.74% to -$9.0 million in 2020, then climbed by 7.46% to -$8.3 million in 2021, then surged by 239.44% to $11.6 million in 2022.
- The last three Net Cash Flow figures came in at $11.6 million (Q4 2022), -$8.3 million (Q4 2021), and -$9.0 million (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 11.57 Mn |
| Dec 31, 2022 | 11.57 Mn |
| Dec 31, 2021 | -8.30 Mn |
| Dec 31, 2021 | -8.30 Mn |
| Dec 31, 2020 | -8.97 Mn |
| Dec 31, 2020 | -8.97 Mn |
| Dec 31, 2019 | -1.87 Mn |
| Dec 31, 2019 | -1.87 Mn |
| Dec 31, 2016 | -11.12 Mn |
| Dec 31, 2016 | -11.12 Mn |
| Dec 31, 2013 | -3.88 Mn |
| Dec 31, 2013 | -3.88 Mn |
| Dec 31, 2012 | 2.56 Mn |
| Dec 31, 2012 | 2.56 Mn |